Global Bio-Sensors for Non-clinical Applications Market Research Report 2022

Biosensors were first introduced in 1962 with the development of enzyme electrodes by scientist Leland C. Clark. Since then, research communities from fields such as very large scale integration, chemistry, physics, and material science have come together to develop more reliable, sophisticated, and mature biosensors. These biosensors found their applications in the field of medicine, biotechnology, agriculture, as well as military and bioterrorism detection and prevention.
Due to the COVID-19 pandemic, the global Bio-Sensors for Non-clinical Applications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Bio-Sensors for Non-clinical Applications market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Bio-Sensors for Non-clinical Applications landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Nanotechnology is an emerging technology that involves the study, creation, manipulation, and use of materials, devices, and systems with dimensions lesser than 100 nm. It also plays a crucial role in the development of biosensors. Nanomaterials not only help introduce several new signal transduction technologies in biosensors but also improve the sensitivity and performance of biosensors. The development of nanotech has resulted in an increase in the applications of nanomaterials in biosensors to a large extent. For example, nanomaterials-based biosensors can significantly increase the sensitivity and specificity of biomolecule detection, detect and manipulate atoms and molecules, and also show potential in applications such as biomolecular recognition, pathogenic diagnosis, and environment monitoring. Moreover, various kinds of nanomaterials, including carbon nanotubes, gold nanoparticles, and quantum dots are being increasingly used in biosensors due to their unique chemical, physical, mechanical, magnetic, and optical properties. The is anticipated to result in the manufacturing of better and more efficient biosensors, leading to their augmented adoption in the coming years.
This report focuses on Bio-Sensors for Non-clinical Applications volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Bio-Sensors for Non-clinical Applications market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Bio-Sensors for Non-clinical Applications Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Piezoelectric
Thermal
Optical
Electrochemical
Segment by Application
Military and Defense
Food and Beverage
Environment Monitoring
Healthcare
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Biosensor Applications
DuPont
Remedios
Smiths Detection

Frequently Asked Questions